Nasdaq · CIK 0001540171
AVLN Avalyn Pharma Inc.
Insider trading from SEC Form 4. Last filing 25 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
1
with a Form 4 at this company
Signals
Open-market buys and sells at Avalyn Pharma Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 1 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Robert J. Meyer director | AGrant or award Stock Option (Right to Buy)derivative | +31,182 | $0.00 | $0 | 31,182 | 25 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.